메뉴 건너뛰기




Volumn 138, Issue 10, 2002, Pages 1359-1365

Long-term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T-cell lymphoma

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

EID: 0036791932     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.138.10.1359     Document Type: Article
Times cited : (69)

References (28)
  • 1
    • 0033966850 scopus 로고    scopus 로고
    • Emerging new therapies for cutaneous T-cell lymphoma
    • Duvic M, Cather JC. Emerging new therapies for cutaneous T-cell lymphoma. Dermatol Clin. 2000;18:147-156.
    • (2000) Dermatol Clin , vol.18 , pp. 147-156
    • Duvic, M.1    Cather, J.C.2
  • 2
    • 0019271714 scopus 로고
    • Cutaneous T-cell lymphoma: Mycosis fungoides, Sézary syndrome, and other variants
    • Edelson RL. Cutaneous T-cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol. 1980;2:89-106.
    • (1980) J Am Acad Dermatol , vol.2 , pp. 89-106
    • Edelson, R.L.1
  • 4
    • 0027512324 scopus 로고
    • Mycosis fungoides: Clinical and histologic features, staging, evaluation, and approach to therapy
    • Abel EA, Wood GS, Hoppe RT. Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to therapy. CA Cancer J Clin. 1993;43:93-113.
    • (1993) CA Cancer J Clin , vol.43 , pp. 93-113
    • Abel, E.A.1    Wood, G.S.2    Hoppe, R.T.3
  • 5
    • 0022899011 scopus 로고
    • The immunopathology of cutaneous lymphomas: Immunophenotypic and immunogenotypic
    • Wood GS, Weiss LM, Warnke RA, et al. The immunopathology of cutaneous lymphomas: immunophenotypic and immunogenotypic. Semin Dermatol. 1986;5:334-345.
    • (1986) Semin Dermatol , vol.5 , pp. 334-345
    • Wood, G.S.1    Weiss, L.M.2    Warnke, R.A.3
  • 6
    • 0026064277 scopus 로고
    • Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
    • Jones RJ, Ambinder RF, Piantadosi S, Santos GW. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood. 1991;77:649-653.
    • (1991) Blood , vol.77 , pp. 649-653
    • Jones, R.J.1    Ambinder, R.F.2    Piantadosi, S.3    Santos, G.W.4
  • 7
    • 0034792086 scopus 로고    scopus 로고
    • T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement
    • Olavarria E, Child F, Woolford A, et al. T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement. Br J Haematol. 2001;114:624-631.
    • (2001) Br J Haematol , vol.114 , pp. 624-631
    • Olavarria, E.1    Child, F.2    Woolford, A.3
  • 8
    • 0034803408 scopus 로고    scopus 로고
    • Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: Predictors of disease-free survival
    • Russel-Jones R, Child F, Olavarria E, Whittaker S, Spittle M, Apperly J. Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: predictors of disease-free survival. Ann N Y Acad Sci. 2001;94:147-154.
    • (2001) Ann N Y Acad Sci , vol.94 , pp. 147-154
    • Russel-Jones, R.1    Child, F.2    Olavarria, E.3    Whittaker, S.4    Spittle, M.5    Apperly, J.6
  • 9
    • 0033023973 scopus 로고    scopus 로고
    • Autologous haematopoietic progenitor transplantation in advanced mycosis fungoides
    • Ferra C, Servitje O, Petriz L, et al. Autologous haematopoietic progenitor transplantation in advanced mycosis fungoides. Br J Dermatol. 1999;140:1188-1189.
    • (1999) Br J Dermatol , vol.140 , pp. 1188-1189
    • Ferra, C.1    Servitje, O.2    Petriz, L.3
  • 10
    • 0028912323 scopus 로고
    • Erythrodermic mycosis fungoides treated with total body irradiation and autologous bone marrow transplantation
    • Sterling JC, Marcus R, Burrows NP, Roberts SO. Erythrodermic mycosis fungoides treated with total body irradiation and autologous bone marrow transplantation. Clin Exp Dermatol. 1995;20:73-75.
    • (1995) Clin Exp Dermatol , vol.20 , pp. 73-75
    • Sterling, J.C.1    Marcus, R.2    Burrows, N.P.3    Roberts, S.O.4
  • 11
    • 0025979542 scopus 로고
    • Autologous bone marrow transplantation for advanced stage mycosis fungoides
    • Bigler RD, Crilley P, Micaily B, et al. Autologous bone marrow transplantation for advanced stage mycosis fungoides. Bone Marrow Transplant. 1991;7:133-137.
    • (1991) Bone Marrow Transplant , vol.7 , pp. 133-137
    • Bigler, R.D.1    Crilley, P.2    Micaily, B.3
  • 12
    • 0022680983 scopus 로고
    • Autologous bone marrow transplantation after supralethal dose of total body irradiation in a case of mycosis fungoides
    • Chen YC, Wang CH, Huang SC, et al. Autologous bone marrow transplantation after supralethal dose of total body irradiation in a case of mycosis fungoides. Taiwan Yi Xue Hui Za Zhi. 1986;85:304-314.
    • (1986) Taiwan Yi Xue Hui Za Zhi , vol.85 , pp. 304-314
    • Chen, Y.C.1    Wang, C.H.2    Huang, S.C.3
  • 13
    • 0001582746 scopus 로고    scopus 로고
    • Allogeneic transplantation for lymphoma produces a lower relapse rate than autologous transplantation, but survival is worse because of higher treatment related mortality: A report of 764 cases from the EBMT lymphoma registration
    • Peniket AJ, Ruiz de Elvira MC, Taghipur G, et al. Allogeneic transplantation for lymphoma produces a lower relapse rate than autologous transplantation, but survival is worse because of higher treatment related mortality: a report of 764 cases from the EBMT lymphoma registration [abstract]. Blood. 1997;93:255.
    • (1997) Blood , vol.93 , pp. 255
    • Peniket, A.J.1    Ruiz de Elvira, M.C.2    Taghipur, G.3
  • 14
    • 0002148681 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for refractory and recurrent follicular lymphoma: A case-matched analysis with autologous transplantation from the French Bone Marrow Transplant Group data registry
    • Molina L, Jouet JP, Pico J, et al. Allogeneic bone marrow transplantation for refractory and recurrent follicular lymphoma: a case-matched analysis with autologous transplantation from the French Bone Marrow Transplant Group data registry [abstract]. Blood. 1997;93:255.
    • (1997) Blood , vol.93 , pp. 255
    • Molina, L.1    Jouet, J.P.2    Pico, J.3
  • 15
    • 0025100777 scopus 로고
    • Graft-versus-leukemia reactions after bone marrow transplantation
    • Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555-562.
    • (1990) Blood , vol.75 , pp. 555-562
    • Horowitz, M.M.1    Gale, R.P.2    Sondel, P.M.3
  • 16
    • 0022622360 scopus 로고
    • Marrow transplantation for the treatment of chronic myelogenous leukemia
    • Thomas ED, Clift RA, Fefer A, et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med. 1986;104:155-163.
    • (1986) Ann Intern Med , vol.104 , pp. 155-163
    • Thomas, E.D.1    Clift, R.A.2    Fefer, A.3
  • 17
    • 0035119772 scopus 로고    scopus 로고
    • Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma
    • Kroger N, Kruger W, Renges H, et al. Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma. Br J Hematol. 2001;112:421-423.
    • (2001) Br J Hematol , vol.112 , pp. 421-423
    • Kroger, N.1    Kruger, W.2    Renges, H.3
  • 18
    • 0035902174 scopus 로고    scopus 로고
    • Haematopoietic cell transplantation as immunotherapy
    • Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411:385-389.
    • (2001) Nature , vol.411 , pp. 385-389
    • Appelbaum, F.R.1
  • 19
    • 0030610153 scopus 로고    scopus 로고
    • Characterization of T cell repertoire in patients with graft-versus-leukemia following donor lymphocyte infusion
    • Claret EJ, Alyea EP, Orsini E, et al. Characterization of T cell repertoire in patients with graft-versus-leukemia following donor lymphocyte infusion. J Clin Invest. 1997;100:855-866.
    • (1997) J Clin Invest , vol.100 , pp. 855-866
    • Claret, E.J.1    Alyea, E.P.2    Orsini, E.3
  • 20
    • 0033951797 scopus 로고    scopus 로고
    • Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: Evidence of a graft-versus-tumor effect
    • Burt RK, Guitart J, Traynor A, et al. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect. Bone Marrow Transplant. 2000;25:111-113.
    • (2000) Bone Marrow Transplant , vol.25 , pp. 111-113
    • Burt, R.K.1    Guitart, J.2    Traynor, A.3
  • 21
    • 0032614112 scopus 로고    scopus 로고
    • Remission of refractory Séary syndrome after bone marrow transplantation from a matched unrelated donor
    • Molina A, Nademanee A, Arber DA, Forman SJ. Remission of refractory Séary syndrome after bone marrow transplantation from a matched unrelated donor. Biol Blood Marrow Transplant. 1999;5:400-404.
    • (1999) Biol Blood Marrow Transplant , vol.5 , pp. 400-404
    • Molina, A.1    Nademanee, A.2    Arber, D.A.3    Forman, S.J.4
  • 22
  • 23
    • 0033661042 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy: Present and future
    • Knobler R. Extracorporeal photochemotherapy: present and future. Vox Sang. 2000;78(suppl 2):197-201.
    • (2000) Vox Sang , vol.78 , Issue.SUPPL. 2 , pp. 197-201
    • Knobler, R.1
  • 24
    • 0010762416 scopus 로고    scopus 로고
    • Graft versus malignancy with allogeneic blood cell transplantation: A potential primary treatment modality
    • Champlin R, Khouri I, Giralt S. Graft versus malignancy with allogeneic blood cell transplantation: a potential primary treatment modality. Pediatr Transplant. 1999;1:522-528.
    • (1999) Pediatr Transplant , vol.1 , pp. 522-528
    • Champlin, R.1    Khouri, I.2    Giralt, S.3
  • 25
    • 79960970719 scopus 로고    scopus 로고
    • Clinical, cytogenetic and molecular remissions after allogeneic hematopoietic stem cell transplantation for refractory Sézary syndrome and tumor-stage mycosis fungoides
    • Abstract 1715
    • Molina A, Arber D, Murata-Collins JL, et al. Clinical, cytogenetic and molecular remissions after allogeneic hematopoietic stem cell transplantation for refractory Sézary syndrome and tumor-stage mycosis fungoides [abstract]. Blood. 2001;98(pt 1):409A. Abstract 1715.
    • (2001) Blood , vol.98 , Issue.PART 1
    • Molina, A.1    Arber, D.2    Murata-Collins, J.L.3
  • 26
    • 0002148681 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for recurrent and follicular lymphoma: A case-matched analysis with autologous transplantation from the French Bone Marrow Transplant registry data
    • Attal M, Socie G, Molina L, et al. Allogeneic bone marrow transplantation for recurrent and follicular lymphoma: a case-matched analysis with autologous transplantation from the French Bone Marrow Transplant registry data [abstract]. Blood. 1997;93(suppl 1):255A.
    • (1997) Blood , vol.93 , Issue.SUPPL. 1
    • Attal, M.1    Socie, G.2    Molina, L.3
  • 27
    • 0030750812 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma
    • Dann, EJ, Daugherty CK, Larson RA. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma. Bone Marrow Transplant. 1997;20:369-374.
    • (1997) Bone Marrow Transplant , vol.20 , pp. 369-374
    • Dann, E.J.1    Daugherty, C.K.2    Larson, R.A.3
  • 28
    • 0010762417 scopus 로고    scopus 로고
    • Matched donor allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: Results from the National Marrow Donor Program
    • Berman P, Molina A, Nelson G, et al. Matched donor allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: results from the National Marrow Donor Program [abstract]. Proc Am Soc Clin Oncol. 1999;18:3A.
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Berman, P.1    Molina, A.2    Nelson, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.